Amylyx ALS Drug May Drive Medicare Part D Redesign Efforts Based On Cost Sharing Concerns

 
• By Cathy Kelly
ALS Patients Worry Payers Will Restrict Access Based On ICER Analysis • Source: Shutterstock

More from Medicare

More from Government Payers